April 1 (Reuters) - Bausch Health Companies Inc BHC.TO :
* SALIX ENTERS INTO LICENSE AGREEMENT WITH THE UNIVERSITY OF CALIFORNIA TO DEVELOP AND COMMERCIALIZE NOVEL COMPOUND FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS